Biallelic loss of function variants in SYT2 cause a treatable congenital onset presynaptic myasthenic syndrome
Open Access
- 10 August 2020
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 182 (10) , 2272-2283
Abstract
Synaptotagmins are integral synaptic vesicle membrane proteins that function as calcium sensors and regulate neurotransmitter release at the presynaptic nerve terminal. Synaptotagmin‐2 (SYT2), is the major isoform expressed at the neuromuscular junction. Recently, dominant missense variants in SYT2 have been reported as a rare cause of distal motor neuropathy and myasthenic syndrome, manifesting with stable or slowly progressive distal weakness of variable severity along with presynaptic NMJ impairment. These variants are thought to have a dominant‐negative effect on synaptic vesicle exocytosis, although the precise pathomechanism remains to be elucidated. Here we report seven patients of five families, with biallelic loss of function variants in SYT2, clinically manifesting with a remarkably consistent phenotype of severe congenital onset hypotonia and weakness, with variable degrees of respiratory involvement. Electrodiagnostic findings were consistent with a presynaptic congenital myasthenic syndrome (CMS) in some. Treatment with an acetylcholinesterase inhibitor pursued in three patients showed clinical improvement with increased strength and function. This series further establishes SYT2 as a CMS‐disease gene and expands its clinical and genetic spectrum to include recessive loss‐of‐function variants, manifesting as a severe congenital onset presynaptic CMS with potential treatment implications.Keywords
Funding Information
- European Research Council (309548)
- Medical Research Council Canada (MR/N025431/1)
- National Human Genome Research Institute (R01 HG009141)
- Newton Fund (MR/N027302/1)
This publication has 31 references indexed in Scilit:
- Responsiveness of the Motor Function Measure in Neuromuscular DiseasesArchives of Physical Medicine and Rehabilitation, 2012
- Synaptotagmin-2 Is Essential for Survival and Contributes to Ca2+Triggering of Neurotransmitter Release in Central and Neuromuscular SynapsesJournal of Neuroscience, 2006
- Different Effects on Fast Exocytosis Induced by Synaptotagmin 1 and 2 Isoforms and Abundance But Not by PhosphorylationJournal of Neuroscience, 2006
- The origin of tubular aggregates in human myopathiesThe Journal of Pathology, 2005
- The C2B Ca2+-binding motif of synaptotagmin is required for synaptic transmission in vivoNature, 2002
- Drosophila synaptotagmin I null mutants survive to early adulthoodGenesis, 2001
- Reference values of maximum isometric muscle force obtained in 270 children aged 4–16 years by hand-held dynamometryNeuromuscular Disorders, 2001
- Functional properties of multiple synaptotagmins in brainNeuron, 1994
- Calcium dependence of neurotransmitter release and rate of spontaneous vesicle fusions are altered in Drosophila synaptotagmin mutants.Proceedings of the National Academy of Sciences, 1994
- A third synaptotagmin gene, Syt3, in the mouse.Proceedings of the National Academy of Sciences, 1994